2m 2m 2m 2m 2m 2m 2m
Standard BioTool (LAB)
NASDAQ
$0.90+$0.05 (+6.15%)
Price as of Jul 14, 2026 4:40 AM EDT- $359.5MMarket Cap
- -32.10%1-Year Change
- Medical DevicesIndustry
Standard BioTool (LAB)
$0.90+$0.05 (+6.15%)
LAB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.85 | ||
Change | -$0.07 (-7.58%) | ||
Open | $0.91 | ||
High | $0.94 | ||
Low | $0.85 | ||
Previous Close | $0.92 | ||
Volume | 1,005,823 | ||
30-Day Average Volume | 5,088,022 | ||
1-Week Change | -4.34% | ||
1-Month Change | -4.38% | ||
1-Year Change | -32.10% | ||
3-Year Change | -65.07% | ||
5-Year Change | -77.72% | ||
Fundamentals | |||
Shares Outstanding | 391.5M | ||
Total Assets | $639.1M | ||
Market Cap | $359.5M | ||
Enterprise Value | $94.0M | ||
Period: QTR TTM FY | |||
Revenue | $15.5M | ||
Net Income | $127.1M | ||
Free Cash Flow | -$47.2M | ||
EBIT | $127.1M | ||
EBITDA | $127.1M | ||
Net Working Capital | $479.3M | ||
EPS | $0.33 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 1 | ||
P/E | 3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue